A functional link between the tumour suppressors ARF and p33ING1

被引:31
|
作者
Gonzalez, L.
Freije, J. M. P.
Cal, S.
Lopez-Otin, C.
Serrano, M.
Palmero, I.
机构
[1] Univ Autonoma Madrid, CSIC, Inst Biomed Res, E-28029 Madrid, Spain
[2] Univ Oviedo, Inst Oncol, Dept Biochem & Mol Biol, Oviedo, Spain
[3] Spanish Natl Canc Ctr, CNIO, Madrid, Spain
关键词
ARF; p53; ING1; tumour suppressor;
D O I
10.1038/sj.onc.1209526
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ARF tumour suppressor protein plays a critical role in the activation of p53 in response to oncogenic stress. ARF can activate p53 through nucleolar sequestration of Mdm2. However, several lines of evidence indicate that this is not the only way of action of ARF, and alternative mechanisms must exist. p33ING1 is a putative tumour suppresor, which induces cell-cycle arrest and apoptosis in a p53-dependent manner. Here, we describe that ARF and p33ING1 can interact in vivo. We also show that the subcellular localization of ING1 can be modulated by ARF protein levels, causing a displacement from nuclear to nucleolar localization. Finally, the ability of p33ING1 to cause cell-cycle arrest and induction of p21CIP1, or Mdm2, is impaired in ARF-deficient primary mouse fibroblasts. Based on these observations, we propose that the interaction with p33ING1 represents a novel mechanism for the tumour suppression function of ARF.
引用
收藏
页码:5173 / 5179
页数:7
相关论文
共 50 条
  • [1] A functional link between the tumour suppressors ARF and p33ING1
    L González
    J M P Freije
    S Cal
    C López-Otín
    M Serrano
    I Palmero
    Oncogene, 2006, 25 : 5173 - 5179
  • [2] Expression of the novel tumour suppressor p33ING1 is independent of p53
    Cheung, KJJ
    Bush, JA
    Jia, W
    Li, G
    BRITISH JOURNAL OF CANCER, 2000, 83 (11) : 1468 - 1472
  • [3] Expression of the novel tumour suppressor p33ING1 is independent of p53
    K-J J Cheung
    J A Bush
    W Jia
    G Li
    British Journal of Cancer, 2000, 83 : 1468 - 1472
  • [4] p33ING1 role in DNA repair
    Cheung, K
    Lin, P
    Ho, V
    Li, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 522 - 522
  • [5] The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control
    Garkavtsev, I
    Grigorian, IA
    Ossovskaya, VS
    Chernov, MV
    Chumakov, PM
    Gudkov, AV
    NATURE, 1998, 391 (6664) : 295 - 298
  • [6] mRNA and protein of p33ING1 in normal and cancer tissues
    Zhao, Shuang
    Zheng, Hua-Chuan
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (05) : 3623 - 3633
  • [7] Bowen病中p33ING1蛋白的表达
    李丽丽
    崔英
    原亮
    王丽梅
    王丽娟
    赵辉
    现代肿瘤医学, 2010, 18 (12) : 2461 - 2462
  • [8] p33ING1基因及其研究进展
    柳剑英
    吴秉铨
    中华病理学杂志, 2001, (04) : 56 - 57
  • [9] Decreased expression of p33ING1 mRNA in lymphoid malignancies
    Ohmori, M
    Nagai, M
    Tasaka, T
    Koeffler, HP
    Riabowol, K
    Takahara, J
    AMERICAN JOURNAL OF HEMATOLOGY, 1999, 62 (02) : 118 - 119
  • [10] Expression of p33ING1 in hepatocellular carcinoma:: Relationships to tumour differentiation and cyclin E kinase activity
    Ohgi, T
    Masaki, T
    Nakai, S
    Morishita, A
    Yukimasa, S
    Nagai, M
    Miyauchi, Y
    Funaki, T
    Kurokohchi, K
    Watanabe, S
    Kuriyama, S
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (12) : 1440 - 1448